METASTATIC OSTEOSARCOMA
Clinical trials for METASTATIC OSTEOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC OSTEOSARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to control tough bone cancer in teens and young adults
Disease control Recruiting nowThis study tests whether combining two drugs, atezolizumab and cabozantinib, can help control osteosarcoma that has come back or spread. It is for adolescents and young adults aged 12 and older whose cancer did not respond to standard treatments. The goal is to slow cancer growth…
Matched conditions: METASTATIC OSTEOSARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Battle of the scalpels: which surgery best halts lung cancer spread in osteosarcoma?
Disease control Recruiting nowThis study compares two surgical methods—open surgery (one large cut) and keyhole surgery (several small cuts with a camera)—to remove osteosarcoma tumors that have spread to the lungs. About 62 patients under 50 with up to 4 lung nodules will be randomly assigned to one of the t…
Matched conditions: METASTATIC OSTEOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug combo aims to improve survival in young bone cancer patients
Disease control Recruiting nowThis study tests whether adding the drug cabozantinib to standard chemotherapy works better than chemo alone for people under 40 with newly diagnosed osteosarcoma, a type of bone cancer. Cabozantinib blocks signals that help tumors grow and form blood vessels. The trial will chec…
Matched conditions: METASTATIC OSTEOSARCOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:40 UTC